GlaxoSmithKline plc (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 166   

Articles published

GSK 42.17 +0.52 (1.25%)
price chart
The Best Way To Play The Looming Superbug Threat [GlaxoSmithKline plc ...
Tags: Cempra Inc, Eli Lilly and Co, GlaxoSmithKline plc (ADR), NASDAQ:CEMP, NYSE:GSK, NYSE:LLY, NYSE:PFE, Pfizer Inc., Tony Daltorio.
GlaxoSmithKline plc (ADR) Mega-Merger Talk: Johnson & Johnson, Roche ...
New takeover rumors for GlaxoSmithKline Plc. (ADR) (NYSE:GSK) emerged Monday. Daily Mail UK reported that UK dealers were speculating Roche Holding Ltd.
GlaxoSmithKline plc. (ADR) (GSK) Sells Two Meningitis Vaccines To Pfizer Inc ...
The need for the said transaction arose, as GSK sought to ease the concerns of regulatory authorities. The company has recently acquired Novartis's NoMenveo and Bexsero vaccines.
Here's How Pfizer Inc., GlaxoSmithKline plc Vaccines Deal Works For Both ...  Bidness ETC
GlaxoSmithKline plc (ADR) (NYSE:GSK) Sells Two Vaccines to Pfizer Inc. (NYSE ...  WallStreetPR (blog)
Analytic Report on GlaxoSmithKline PLC (ADR) (NYSE:GSK)
[Financial Times] GlaxoSmithKline PLC (ADR) (NYSE:GSK)(TREND ANALYSIS) Broker theorising about a �90bn takeover was greeted with a shrug by GlaxoSmithKline shareholders.
Pre Movers- ANN INC. (NYSE:ANN), GlaxoSmithKline plc (NYSE:GSK), HSBC ...  StreetWise Report
Stocks with High ROA: Supernus Pharmaceuticals Inc (NASDAQ:SUPN ...
In the last 12 months, GlaxoSmithKline plc (ADR) (NYSE:GSK) generated 20.78% using assets of the company. Reuters provide figures showing that industry's suggest 12.74% and broadly in sector 8.32% seems favorable.
GlaxoSmithKline plc (ADR) Committed To New Drug Discovery; Will Invest $95 ...
GlaxoSmithKline plc. (ADR) (NYSE:GSK) announced it will invest $95 million to manufacture a new research institute in Seattle called Altius Institute for Biomedical Sciences, as the company looks to speed up new drugs discovery and development.
GlaxoSmithKline plc. (ADR) (NYSE:GSK) All Ready to Fund a New Institute in ...
Decliners: GlaxoSmithKline plc (GSK), Centurylink (CTL), Cerner (CERN ...  Techsonian (press release)
GlaxoSmithKline plc (ADR) Offloaded Drugs Surge To $5 Billion In Value; Is The ...
GlaxoSmithKline plc (ADR) (NYSE:GSK) has not been making the best decisions lately. The biotech giant is already facing significant pressure on earnings due to cheaper drug competition, a recent bribery scandal in China, and poor stock performance.
GlaxoSmithKline plc (ADR) Considers Changes To Its US Sales Staff ...
GlaxoSmithKline plc (ADR) (NYSE:GSK) has been undergoing a seemingly rough patch in its US operations over the past year.
GlaxoSmithKline plc (ADR) (GSK) Prepares Major Turnaround
GlaxoSmithKline plc (ADR) (NYSE:GSK) reported first-quarter fiscal'15 (1QFY15) earnings yesterday, with CEO Andrew Witty providing investors a much-needed future outlook for the company stock and a detailed 2015 guidance.
GlaxoSmithKline Plc (ADR) (NYSE:GSK) Unveils Big Business Growth Targets  WallStreetPR (blog)
Glaxo (GSK) Misses on Q1 Earnings, Gives 5-Year Outlook
GlaxoSmithKline plc (ADR) (GSK) Q1 Earnings Preview: What To Expect
GlaxoSmithKline plc (ADR) (NYSE:GSK) plans to report its first-quarter fiscal year 2015 (1QFY15) earnings data during market hours on May 6. Analysts expect the company's earnings to continue with their downward spiral, while they think a promising ...